Browse our anti-IER3 (IER3) Antibodies

Full name:
anti-Immediate Early Response 3 Antibodies (IER3)
On are 46 Immediate Early Response 3 (IER3) Antibodies from 15 different suppliers available. Additionally we are shipping IER3 Kits (7) and IER3 Proteins (6) and many more products for this protein. A total of 63 IER3 products are currently listed.
AI663993, cI-3, DIF-2, Dif2, gly96, IER3, IEX-1, IEX-1L, Iex1, Ler3, Prg1
list all antibodies Gene Name GeneID UniProt
IER3 8870 P46695
IER3 15937  
IER3 294235  

Show all species

Show all synonyms

Most Popular Reactivities for anti-IER3 (IER3) Antibodies

Select your species and application

anti-Human IER3 Antibodies:

anti-Mouse (Murine) IER3 Antibodies:

anti-Rat (Rattus) IER3 Antibodies:

All available anti-IER3 Antibodies

Go to our pre-filtered search.

Top referenced anti-IER3 Antibodies

  1. Human Polyclonal IER3 Primary Antibody for FACS, IF - ABIN655735 : Fellay, Ge, Shianna, Colombo, Ledergerber, Cirulli, Urban, Zhang, Gumbs, Smith, Castagna, Cozzi-Lepri, De Luca, Easterbrook, Günthard, Mallal, Mussini, Dalmau, Martinez-Picado, Miro, Obel, Wolinsky, Martinson, Detels, Margolick, Jacobson, Descombes, Anton: Common genetic variation and the control of HIV-1 in humans. in PLoS genetics 2009 (PubMed)
    Show all 3 references for 655735

  2. Human Polyclonal IER3 Primary Antibody for EIA, FACS - ABIN952818 : Ouakaa-Kchaou, Elloumi, Kochlef, Gargouri, Kharrat, Kilani, Ghorbel: Ovarian Crohn's disease. in Journal of Crohn's & colitis 2010 (PubMed)
    Show all 2 references for 952818

  3. Human Polyclonal IER3 Primary Antibody for ELISA, ICC - ABIN4321045 : Akilov, Wu, Ustyugova, Falo, Geskin: Resistance of Sézary cells to TNF-α-induced apoptosis is mediated in part by a loss of TNFR1 and a high level of the IER3 expression. in Experimental dermatology 2012 (PubMed)

More Antibodies against IER3 Interaction Partners

Human Immediate Early Response 3 (IER3) interaction partners

  1. we determined the molecular mechanism responsible for IER3 degradation, involving a ternary complex of IER3, MDM2 (show MDM2 Antibodies) and FHL2 (show FHL2 Antibodies), which may contribute to cervical tumor growth. Furthermore, we demonstrated that FHL2 (show FHL2 Antibodies) serves as a scaffold for E3 ligase and its substrate during the ubiquitination reaction, a function that has not been previously reported for this protein

  2. Analysis of consensus EGR (show EGR1 Antibodies)-binding elements (EBEs) showed that the immediate early response 3 gene (IER3) is a novel transcriptional target gene of EGR2 (show EGR2 Antibodies) as confirmed by the luciferase assay, electrophoretic mobility-shift assay (EMSA), chromatin immunoprecipitation (ChIP), and western blot analysis.

  3. Study characterized IEX-1's expression and function in rheumatoid arthritis synovial fibroblasts and showed that IEX-1 is highly expressed in RA-SFs and negatively regulates RA-SF activation.

  4. interleukin-1beta (IL-1beta (show IL1B Antibodies))-induced IER3 expression is mediated by the ERK1/2 (show MAPK1/3 Antibodies) target, transcription factor Elk-1 (show ELK1 Antibodies).

  5. findings suggest that IER3 is a putative tumor suppressor in the cervix, and the c-Ab1/p73beta/IER3 axis is a novel and crucial signaling pathway that confers etoposide chemosensitivity.

  6. High expression of IER3 is associated with hepatocarcinoma.

  7. In human samples removed from failed AVF, there was a significant increase in IEX-1 expression localized to the adventitia.

  8. IEX-1 expression levels correlate with the severity of preeclampsia

  9. Studied the binding effect of hcmv-miR (show MLXIP Antibodies)-UL148D to the 3' untranslated region (3'UTR (show UTS2R Antibodies)) of IEX-1.Results showed that only one binding site in the 3'UTR (show UTS2R Antibodies) of IEX-1 was completely complementary to an 11nt sequence in the 5' terminus of hcmv-mir (show MLXIP Antibodies)-UL148D.

  10. the interference of IER3 with the PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies)-Fyn (show FYN Antibodies) pathway represents a novel mechanism of Nrf2 (show GABPA Antibodies) regulation that may get lost in tumors and by which IER3 exerts its stress-adaptive and tumor-suppressive activity.

Mouse (Murine) Immediate Early Response 3 (IER3) interaction partners

  1. IER3 expression is blunted during heart failure development in a titin (show TTN Antibodies)-deficient mouse model.

  2. these results indicate that IER3 is a key player in expanding the pool of APC (show APC Antibodies) while highlighting the role of distinct effectors found in an obese microenvironment in this process

  3. Loss of IEX-1 results in reduced VNH accompanied with a decrease in proliferation, reduced fibroblast, myofibroblast, and Ly6C staining accompanied with increased apoptosis mediated through a reduction in Vegf-A (show VEGFA Antibodies)/Mcp-1 (show CPT1B Antibodies) axis and Mmp-9 (show MMP9 Antibodies).

  4. IER3 supports KRASG12D-associated oncogenesis in the pancreas by sustaining ERK1/2 (show MAPK1/3 Antibodies) phosphorylation via phosphatase PP2A (show PPP2R2B Antibodies) inhibition.

  5. Stress-induced hematopoietic failure in the absence of immediate early (show JUN Antibodies) response gene X-1 (IEX-1, IER3).

  6. the interference of IER3 with the PI3K/Akt (show AKT1 Antibodies)-Fyn (show FYN Antibodies) pathway represents a novel mechanism of Nrf2 (show NFE2L2 Antibodies) regulation that may get lost in tumors and by which IER3 exerts its stress-adaptive and tumor-suppressive activity.

  7. IEX-1 has a role in activation of Erk (show EPHB2 Antibodies) and NF-kB pathways, which affects thrombopoietin (show THPO Antibodies)-promoted NHEJ DNA repair in hematopoietic stem cells

  8. Data suggest a role for the immediate early (show JUN Antibodies) response gene X-1 (IEX-1) in the control of colon epithelial homeostasis.

  9. Our present investigation shows that null mutation of IEX-1 promotes differentiation of Th17 cells but compromises the survival of Th1 (show HAND1 Antibodies) cells

  10. IER3 plays a complex and to some extent contradictory role in cell cycle control and apoptosis. Effects of IER3 relate to an interference with certain signalling pathways

IER3 Antigen Profile

Antigen Summary

This gene functions in the protection of cells from Fas- or tumor necrosis factor type alpha-induced apoptosis. Partially degraded and unspliced transcripts are found after virus infection in vitro, but these transcripts are not found in vivo and do not generate a valid protein.

Alternative names and synonyms associated with IER3

  • immediate early response 3 (IER3) antibody
  • immediate early response 3 (Ier3) antibody
  • AI663993 antibody
  • cI-3 antibody
  • DIF-2 antibody
  • Dif2 antibody
  • gly96 antibody
  • IER3 antibody
  • IEX-1 antibody
  • IEX-1L antibody
  • Iex1 antibody
  • Ler3 antibody
  • Prg1 antibody

Protein level used designations for IER3

immediate early response 3 , radiation-inducible immediate-early gene IEX-1 , ATP-binding cassette, sub-family F (GCN20), member 1 , PACAP-responsive gene 1 protein , anti-death protein , differentiation-dependent gene 2 protein , expressed in pancreatic carcinoma , gly96, mouse, homolog of , immediate early protein GLY96 , immediate early response 3 protein , immediately early gene X-1 , protein DIF-2 , cAMP inducible gene 3

481708 Canis lupus familiaris
505455 Bos taurus
701939 Macaca mulatta
743437 Pan troglodytes
8870 Homo sapiens
15937 Mus musculus
294235 Rattus norvegicus
462547 Pan troglodytes
Selected quality suppliers for anti-IER3 (IER3) Antibodies
Did you look for something else?